Bridging the boundaries between scientists and clinicians—mechanistic hypotheses and patient stories in risk assessment of drugs

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Evaluation In Clinical Practice

• Publication date

  2017-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/jep.12622PMID 27538494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bridging the boundaries between scientists and clinicians—mechanistic hypotheses and patient stories in risk assessment of drugs

  2017cited by this paper
• Burden of Rotavirus Disease in Norway: Using National Registries for Public Health Research

  2016cited by this paper
• Primary vaccine failure to routine vaccines: Why and what to do?

  2016cited by this paper
• Unpacking knowledge translation in participatory research: a micro-level study

  2016cited by this paper
• Until RCT proven? On the asymmetry of evidence requirements for risk assessment.

  2013cited by this paper
• Protocol for a qualitative study of knowledge translation in a participatory research project

  2013cited by this paper
• Considerations on causality in pharmacovigilance

  2012cited by this paper
• Pharmacovigilance.

  2012cited by this paper
• An agenda for UK clinical pharmacology: Pharmacovigilance

  2012cited by this paper
• Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway.

  2012cited by this paper
• Drug-Induced Renal Calculi

  2012cited by this paper
• The cultural divide: exploring communication barriers between scientists and clinicians

  2011cited by this paper
• The human biology--saturated with experience.

  2011cited by this paper
• The Philosophy of Evidence-Based Medicine: Howick/The Philosophy of Evidence-Based Medicine

  2011cited by this paper
• Effect of Population Heterogenization on the Reproducibility of Mouse Behavior: A Multi-Laboratory Study

  2011cited by this paper
• Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function.

  2010cited by this paper
• Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

  2009cited by this paper
• The evolution of evidence hierarchies: what can Bradford Hill's ‘guidelines for causation’ contribute?

  2009cited by this paper
• Cisapride and ventricular arrhythmia.

  2008cited by this paper
• Pursuing common agendas: a collaborative model for knowledge translation between research and practice in clinical settings.

  2008cited by this paper
• Helicobacter Connections

  2006cited by this paper
• Anecdotes that provide definitive evidence

  2006cited by this paper
• Hempelian and Kuhnian approaches in the philosophy of medicine: the Semmelweis case.

  2005cited by this paper
• Temporal trends in spontaneous reporting of unlabelled adverse drug reactions.

  2003cited by this paper
• Serious ventricular arrhythmias among users of cisapride and other QT‐prolonging agents in the United States

  2002cited by this paper
• What Evidence in Evidence‐Based Medicine?

  2002cited by this paper
• The patient-centred interview: the key to biopsychosocial diagnosis and treatment.

  2001cited by this paper
• Spontaneous adverse event signaling methods: classification and use with health care treatment products.

  2001cited by this paper
• In Defense of Case Reports and Case Series

  2001cited by this paper
• Adverse drug reactions: definitions, diagnosis, and management.

  2000cited by this paper
• Spontaneous reporting--of what? Clinical concerns about drugs.

  1999cited by this paper
• The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada.

  1999cited by this paper
• Endothelium-Derived Relaxing Factor: Discovery, Early Studies, and Identification as Nitric Oxide

  1999cited by this paper
• Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval.

  1998cited by this paper
• QT Interval in Children and Infants Receiving Cisapride

  1998cited by this paper
• Who cares about pharmacovigilance?

  1997cited by this paper
• [Medical birth registries a gold mine for research].

  1993cited by this paper
• Tachycardia during cisapride treatment.

  1992cited by this paper

• When Patient Voices Get Lost in Evidence Hierarchies: A Testimony of Rare Adverse Events and Participatory Epistemic Injustice in Drug Safety Monitoring

  2024cites this paper
• The reliability of evidential pluralism in drug regulation

  2024cites this paper
• The circular paradox of including people with severe brain injuries and reduced decisional capacity in research: A feasibility study exploring randomized research, consent-based recruitment biases, and the resultant health inequities

  2023cites this paper
• The Value of Case Reports for Graduate Medical Education.

  2022cites this paper
• Evidence of Biological Mechanisms and Health Predictions: An Insight into Clinical Reasoning

  2022cites this paper
• Characterizing interdisciplinarity in drug research: A translational science perspective

  2021cites this paper
• Chapter 3 Probability for the Clinical Encounter

  2020cites this paper
• Probability for the Clinical Encounter

  2020cites this paper
• Causal Insights from Failure: Post-marketing Risk Assessment of Drugs as a Way to Uncover Causal Mechanisms

  2020influential citation
• Causal Evidence and Dispositions in Medicine and Public Health

  2020cites this paper
• Artificial intelligence methods for a Bayesian epistemology-powered evidence evaluation.

  2020cites this paper
• The Guidelines Challenge

  2020cites this paper
• When a Cause Cannot Be Found

  2020cites this paper
• Pharmacovigilance as Scientific Discovery: An Argument for Trans-Disciplinarity

  2019cites this paper
• The guidelines challenge-Philosophy, practice, policy.

  2018cites this paper
• What is the guidelines challenge? The CauseHealth perspective.

  2018cites this paper
• Bridging the boundaries between scientists and clinicians—mechanistic hypotheses and patient stories in risk assessment of drugs

  2017cites this paper